The portfolio will comprise 20-25 B2B startups spanning Pre-seed to Series A stages, addressing innovation gaps in areas such as pharmaceuticals, biotechnology, medical technology, specialty chemicals ...
Aalok Shanghvi completed his graduation in Cellular and Molecular Biology from the University of Michigan, US.
The BioSecure Act seeks to reduce US-China biotech ties, creating potential for India to become a biomanufacturing hub.
India’s pharmaceutical industry is poised for significant growth, with its share in the global market expected to rise to 5 ...
The firm has claimed that it is the first such vaccine in the world for the highly infectious viral disease that affects ...
Bharat Biotech's group company, Biovet, has launched the world's first-ever Lumpy Skin Disease (LSD) vaccine, Biolumpivaxin, ...
In February 2024, the government slashed GST (Goods and Services Tax) from three major cancer drugs: Trastuzumab Deruxtecan, ...
The Cyber Cell of Delhi Police, India, has arrested a Nigerian national, Patrick Ngomere, for allegedly hacking the email ...
India’s contract research (CRO), development and manufacturing (CDMO) services markets doubled between 2019 and 2023 ...
India's pharmaceutical exports are projected to reach US$ 350 billion by 2047, driven by specialty generics, biosimilars, and APIs.
The Indian pharma market, currently valued at around USD 55 billion, is projected to expand 2.2 to 2.4 times over the next ...